Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Results status updated from 'No Results Posted' to 'Results Submitted'. This indicates that trial results have been submitted for posting.
    Difference
    0.1%
    Check dated 2026-04-02T15:42:01.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:20:45.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:42.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Updated sponsor/collaborator naming to Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. Removed the former names Sidney Kimmel Cancer Center at Thomas Jefferson University and the parenthetical Thomas Jefferson University (Sidney Kimmel Cancer Center at Thomas Jefferson University).
    Difference
    0.3%
    Check dated 2026-02-25T19:43:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page adds a new Revision: v3.4.2 and removes an older funding-status notice and Revision: v3.4.1; these are administrative updates that do not alter trial details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:08:14.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a government funding notice and a site revision (v3.4.1); removed the prior revision (v3.4.0); core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:36:41.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.